Free Trial

Bausch Health Companies (BHC) Stock Forecast & Price Target

$8.40
+0.15 (+1.82%)
(As of 10/15/2024 ET)

Bausch Health Companies - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
4
Buy
1

Based on 6 Wall Street analysts who have issued ratings for Bausch Health Companies in the last 12 months, the stock has a consensus rating of "Hold." Out of the 6 analysts, 1 has given a sell rating, 4 have given a hold rating, and 1 has given a buy rating for BHC.

Consensus Price Target

$7.33
-12.65% Downside
According to the 6 analysts' twelve-month price targets for Bausch Health Companies, the average price target is $7.33. The highest price target for BHC is $9.00, while the lowest price target for BHC is $3.00. The average price target represents a forecasted downside of -12.65% from the current price of $8.40.
Get the Latest News and Ratings for BHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Bausch Health Companies and its competitors.

Sign Up

BHC Analyst Ratings Over Time

TypeCurrent Forecast
10/16/23 to 10/15/24
1 Month Ago
9/16/23 to 9/15/24
3 Months Ago
7/18/23 to 7/17/24
1 Year Ago
10/16/22 to 10/16/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$7.33$7.33$10.50$12.50
Forecasted Upside-12.65% Downside16.03% Upside37.80% Upside69.15% Upside
Consensus Rating
Hold
Hold
Hold
Hold

BHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Bausch Health Companies Stock vs. The Competition

TypeBausch Health CompaniesMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.79
2.50
Consensus RatingHoldModerate BuyHold
Predicted Upside-12.65% Downside10,351.19% Upside6.70% Upside
News Sentiment Rating
Neutral News

See Recent BHC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/7/2024Jefferies Financial Group
2 of 5 stars
 Lower TargetBuy$13.00 ➝ $9.00+70.78%
8/2/2024Royal Bank of Canada
4 of 5 stars
 Lower TargetSector Perform ➝ Sector Perform$10.00 ➝ $8.50+49.65%
8/2/2024Scotiabank
5 of 5 stars
 Lower TargetSector Perform$10.00 ➝ $8.50+47.57%
8/2/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight$9.00 ➝ $3.00-50.82%
7/25/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$8.00 ➝ $7.00+18.85%
7/10/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Nachman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$8.00+11.19%
6/16/2023TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:39 PM ET.


BHC Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Bausch Health Companies is $7.33, with a high forecast of $9.00 and a low forecast of $3.00.

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last year. There is currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BHC, but not buy additional shares or sell existing shares.

According to analysts, Bausch Health Companies's stock has a predicted downside of -12.65% based on their 12-month stock forecasts.

Over the previous 90 days, Bausch Health Companies's stock had 1 downgrade by analysts.

Bausch Health Companies has been rated by research analysts at Jefferies Financial Group, Piper Sandler, Royal Bank of Canada, Scotiabank, and Truist Financial in the past 90 days.

Analysts like Bausch Health Companies less than other "medical" companies. The consensus rating for Bausch Health Companies is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how BHC compares to other companies.


This page (NYSE:BHC) was last updated on 10/15/2024 by MarketBeat.com Staff
From Our Partners